The importance of dosing intravenous calcitriol in dialysis patients with severe hyperparathyroidism

Marked suppression of secondary hyperparathyroidism by intravenous administration of 1,25-dihydroxy-cholecalciferol in uremic patients.

Eduardo Slatopolsky, Carol Weerts, J Thielan et al. · Journal of Clinical Investigation · 1984 · 686 citations · Full text

Medicine, Endocrinology, Pharmacology +15

Decreased 1,25-dihydroxyvitamin D3 receptor density is associated with a more severe form of parathyroid hyperplasia in chronic uremic patients.

Nobuto Fukuda, Hideaki Tanaka, Yohei Tominaga et al. · Journal of Clinical Investigation · 1993 · 599 citations · Full text

Medicine, Endocrinology, Nephrology +11

Intravenous Calcitriol in the Treatment of Refractory Osteitis Fibrosa of Chronic Renal Failure

Dennis L. Andress, Keith C. Norris, J. W. Coburn et al. · New England Journal of Medicine · 1989 · 323 citations

Medicine, Endocrinology, Nephrology +16

Reduced Binding of [³H]l,25-Dihydroxyvitamin D₃in the Parathyroid Glands of Patients with Renal Failure

Adel B. Korkor · New England Journal of Medicine · 1987 · 272 citations

Medicine, Endocrinology, Nephrology +10

Prospective trial of pulse oral versus intravenous calcitriol treatment of hyperparathyroidism in ESRD

L. Darryl Quarles, Daniel A. Yohay, Barbara A. Carroll et al. · Kidney International · 1994 · 252 citations

Medicine, Endocrinology, Nephrology +10